InvestorsHub Logo
Followers 0
Posts 22925
Boards Moderated 1
Alias Born 10/28/2010

Re: 1~Eye~Jack!! post# 17507

Wednesday, 09/09/2015 10:40:13 PM

Wednesday, September 09, 2015 10:40:13 PM

Post# of 118384
~ RGBP = Yawn,, Been hearing "FDA Approval"for..this..Science..for..yearsZZZzz!..frown

http://investorshub.advfn.com/Bio-Matrix-Scientific-Group-Inc-BMSN-6801/?NextStart=80120

Billions and Billions of Shares Diluted since then.... frown = BMSN O/S
http://ih.advfn.com/p.php?pid=nmona&article=68130817

There were 4,232,931,245 shares of Common Stock outstanding as of June 30, 2015.

Yikes!,, Those #'s are only good for a Burger Joint on amount of Burgers served! frown

~~~ Now Koos, aka"Dr. Dilutions," is moving all the Bills from Over-Diluted BMSN to RGBP!! frown

The MONTHLY Rent Payments to ENTB for $5000,,, & to Thomas Ichim shall be paid salary at the rate of $10,000 per month,, & Christine Ichim shall be paid salary at the rate of $6,000 per month,, are NOT Restricted Shares! frown
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116550717

...and Don't forget the Thousands & Thousands going Out each Month to Pay David Koos and Todd S. Caven , who serve as the Company's Principal Executive Officer and Principal Financial Officer!! frown
http://ih.advfn.com/p.php?pid=nmona&article=67931748

O/S keeps Grow'n Monthy! frown ...it is LOCK'd in!! frown

..so Sad! frown


& these New Dilutions Transferred to RGBP, Also! frown

8k = http://ih.advfn.com/p.php?pid=nmona&article=68309040&symbol=RGBP

On August 1, 2015 that agreement for a license grant of intellectual property to Regen Biopharma,Inc. (“Regen”) by Benitec Australia Limited (“Benitec”) dated August 5, 2013 (“Agreement”) was amended as follows:

Any License Fees or Milestone Payments ( as those terms are defined in the Agreement”) to be paid subsequent to April 6, 2015 may be paid in the common stock of Regen. frown


...so sad! frown

such common stock would be issued at Regen Biopharma’s discretion and, in the event that Regen Biopharma doesn’t have enough authorized shares available to issue, Regen Biopharma may increase the authorized shares so as to allow payment to Benitec Australia.


OOOuch! frown